What Tianeptine Is and Why “Gas Station Heroin” Became a Hidden Addiction Problem in Tennessee Convenience Stores
For a long time it sat in plain sight: a small colorful bottle by the register at a gas station or vape shop, marketed as a mood booster or a “cognitive” supplement. The active ingredient in many of those bottles is tianeptine, and the street name it earned tells you most of what you need to know. People call it “gas station heroin” because, at the doses sold in these products, it behaves in the body a lot like an opioid.
Tianeptine is a real antidepressant. It is approved and prescribed in parts of Europe, Asia, and Latin America for major depressive disorder. What it is not is approved in the United States. The U.S. Food and Drug Administration has never cleared tianeptine for any medical use here, does not consider it a lawful dietary ingredient, and has repeatedly warned consumers to avoid products that contain it.
That gap between “sold at the counter” and “not actually legal or safe” is where the trouble lives. This guide explains what tianeptine does, how Tennessee law treats it, what the data shows, and what real treatment for tianeptine dependence looks like. It is informational only and is not medical or legal advice.
How Tianeptine Acts as a Full Mu-Opioid Receptor Agonist and Why High-Dose Use Produces Opioid-Like Dependence
The pharmacology is the reason the nickname stuck. At standard therapeutic doses, tianeptine works as an atypical antidepressant. But laboratory research, notably work by Gassaway and colleagues published in 2014, established that tianeptine is a full agonist at the mu-opioid receptor, the same receptor engaged by morphine, oxycodone, and heroin. When people take the supratherapeutic amounts found in many retail products, the opioid side of that activity dominates: euphoria, sedation, and, with repeated use, tolerance, dependence, and withdrawal.
Because tianeptine has a short duration of action, users often redose many times a day and escalate quickly. Clinicians reviewing U.S. cases describe a pattern of rapid dose escalation that patients rarely see coming, precisely because the product looked like a supplement rather than a drug. The marketing and the reality diverge sharply, which is worth laying out plainly.
| How it is marketed | What the FDA and research indicate |
|---|---|
| A mood or “brain function” supplement | Not FDA-approved for any use; not a lawful dietary ingredient |
| Safely treats anxiety, depression, or pain | FDA calls these claims unproven; some products also contained synthetic cannabinoids |
| A legal alternative to opioids | Acts as a full mu-opioid agonist and can cause opioid-like dependence |
| Low-risk and consumer-friendly | Linked in FDA reports to seizures, respiratory depression, and death |
The Brand Names Tianeptine Hides Behind on Tennessee Shelves — Zaza, Tianaa, Pegasus, TD Red, and Neptune’s Fix
One reason tianeptine slipped past so many people is that it rarely announces itself. It has been sold under a rotating cast of brand names, often in cherry, lemon, or vanilla flavors and in both pill and liquid form. Names that regulators and reporters have repeatedly flagged include Zaza and Zaza Red, Tianaa, Pegasus, TD Red, and Neptune’s Fix. If you have seen any of these near a register in Tennessee, you have seen the product this article is about.
Neptune’s Fix became the flashpoint. In early 2024, after a cluster of poisonings in New Jersey and a string of severe adverse-event reports, the manufacturer issued a nationwide voluntary recall of its elixir and tablet products. Investigators who analyzed some of those bottles found not only tianeptine but synthetic cannabinoids as well, a reminder that with unregulated products, what is on the label is not always what is inside.
Tennessee’s Schedule II Tianeptine Law and What the 2022 Ban Means for Possession and Sale in 2026
Tennessee acted earlier than most states. Under Tennessee Code Annotated § 39-17-408, tianeptine, along with its salts and chemically equivalent preparations, is listed as a Schedule II controlled substance. That classification was added by Public Chapter 1135 (Senate Bill 1997 and House Bill 2043) and took effect on July 1, 2022. In practical terms, over-the-counter sales at gas stations and smoke shops became illegal on that date, and local police in several Tennessee communities began pulling bottles off shelves soon after.
| Tennessee status | Detail |
|---|---|
| Legal classification | Schedule II controlled substance, Tenn. Code § 39-17-408 |
| Governing act | Public Chapter 1135 (SB1997 / HB2043) |
| Effective date | July 1, 2022 |
| Scope | Covers substances chemically equivalent to tianeptine |
| Possession penalty | Class A misdemeanor (up to 11 months, 29 days; fine up to $2,500) |
| Sale or manufacture | Prosecuted as a felony under the state Drug Control Act |
Tennessee’s own health agency has documented why the state cared. The Tennessee Department of Health’s 2024 Tianeptine Trend Report noted fatal overdose cases in the state involving tianeptine, and it reaffirmed the drug’s Schedule II status and high potential for abuse. Statewide, that is the backdrop against which people now seek treatment; our overview of the best places in Tennessee for luxury drug and alcohol rehab shows where private care is concentrated.
Tennessee’s Schedule II classification of tianeptine took effect, ending over-the-counter sales.
The FDA issued a public safety alert urging consumers to avoid all tianeptine products.
Neptune Resources issued a nationwide voluntary recall of its Neptune’s Fix products.
The FDA renewed its warnings as poison-center calls involving tianeptine climbed.
What Federal FDA Alerts and U.S. Poison Center Data Reveal About the Rising Tianeptine Danger Nationwide
The regulatory attention tracks a steep rise in harm. According to the FDA, poison-center cases involving serious side effects from tianeptine grew from 11 total between 2000 and 2013 to 151 in the single year 2020. America’s Poison Centers later reported 391 tianeptine cases nationwide in 2023. The trajectory is hard to miss.
The clinical literature fills in what those calls involve. A 2026 systematic review in the journal Drug and Alcohol Dependence pulled together published tianeptine cases and found a roughly even split between people arriving in withdrawal and people arriving in overdose. Overdose presentations frequently involved central nervous system depression, respiratory failure, and rhabdomyolysis, and a meaningful share of patients needed intensive care.
Among 52 individual cases reviewed, about 50 percent presented in withdrawal and about 44 percent presented in overdose.
Across a larger retrospective pool of 1,007 cases, roughly 22 percent required intensive care.
Among overdose cases with detailed data, naloxone was given in about 27 percent, and fatalities occurred in about 32 percent.
The FDA has also flagged how concentrated some retail products became, reporting that certain U.S. products contained up to 250 times the recommended dosage used for approved foreign drug products. Combined with inconsistent labeling, that is a recipe for accidental overdose.
Recognizing Tianeptine Withdrawal Symptoms and Understanding the Fast-Onset Detox Timeline
Because tianeptine engages opioid receptors, stopping after regular high-dose use tends to trigger opioid-like withdrawal. Case reports describe anxiety, agitation, gastrointestinal distress, sweating, insomnia, and strong cravings. There is an added wrinkle specific to tianeptine: since many people started using it to self-treat mood problems, stopping can also bring a rebound of depression or anxiety, which needs its own attention during recovery.
The drug’s short duration of action means withdrawal can start quickly, often within hours of the last dose rather than the next day. The general course clinicians describe looks like this, though it varies with dose and duration of use.
often within hours
first day or two
several days
can linger
A word of caution on quitting abruptly.
Tianeptine withdrawal can be intense and can begin fast. Case reports document patients needing medication just to get through it. If you use these products daily, talking with a licensed medical provider before you stop is safer than trying to power through alone.
What Evidence-Based, Medically Supervised Treatment for Tianeptine Use Disorder Actually Involves
Because tianeptine dependence behaves so much like opioid use disorder, treatment borrows the same evidence-based toolkit. Across the published case reports and reviews, buprenorphine (often as buprenorphine-naloxone) is described as a first-line option for managing tianeptine withdrawal and supporting abstinence. Some patients need higher buprenorphine doses than usual because tianeptine binds the receptor tightly. Clonidine helps blunt physical symptoms, and gabapentin has been used for agitation and hypersensitivity. In acute overdose, naloxone may reverse effects, though clinicians note its results can be variable.
Two points matter for anyone choosing a program. First, timing of medication is a clinical judgment that belongs with an experienced provider, since starting buprenorphine at the wrong moment relative to a full opioid agonist can precipitate withdrawal. Second, durable recovery usually means treating the mood or anxiety symptoms that drew a person to tianeptine in the first place, not just clearing the drug. A program that ignores the depression piece is treating half the problem.
What Distinguishes a Luxury or Private Tianeptine Rehab Facility in Tennessee From Standard Outpatient Care
The word “luxury” gets attached to a lot of nice photography, but for tianeptine specifically the substance that matters is clinical: on-site or closely coordinated medical detox, experienced medication management, and integrated care for co-occurring depression and anxiety. Private and luxury programs in Tennessee tend to add smaller caseloads, more one-on-one clinician time, private accommodations, and holistic therapies that make a longer stay easier to complete. Those comforts are genuinely useful, but they should sit on top of real medical capability, not stand in for it.
The levels of care below make up the standard continuum. Many people move through more than one as they stabilize.
| Level of care | What it typically involves | Often suited to |
|---|---|---|
| Medical detox | 24-hour monitoring, comfort medications | Daily or high-dose use |
| Residential inpatient | Live-in care with medical oversight | Significant dependence |
| Partial hospitalization | Full-day structure, home at night | Step-down or moderate needs |
| Intensive outpatient | Several sessions weekly around work | Milder dependence, strong support |
| Outpatient MAT | Ongoing medication and counseling | Maintenance and relapse prevention |
Cost and setting vary widely across the state. If you are comparing premium options, our look at the most expensive luxury rehab facilities in Tennessee and our guide to the top cities for luxury detox, executive rehab, and premium inpatient treatment give a sense of what different levels of care cost and where they sit. Because tianeptine use disorder is treated much like opioid dependence, most plans that cover addiction treatment apply; our breakdown of luxury rehab in Tennessee accepted through insurance coverage explains how to check your benefits.
How to Verify the Accreditation, Licensing, and Clinical Credibility of a Luxury Tianeptine Rehab Provider in Tennessee
“Luxury” is not a regulated term, so it pays to look past the marketing. A few verifiable markers separate a serious clinical program from a comfortable-looking one. Look for accreditation from the Joint Commission or CARF, both independent bodies that audit safety and quality. Confirm state licensing through the Tennessee Department of Mental Health and Substance Abuse Services. Ask directly whether the program offers medical detox and prescribes buprenorphine, since tianeptine withdrawal often calls for both.
It is also fair to ask how a facility handles the details the case reports emphasize: how they time medication, how they manage patients who were taking very high doses, and how they treat co-occurring depression once the drug clears. A provider that answers those clearly is showing the kind of expertise that actually matters here. Vague reassurance, pressure to commit on the spot, or reluctance to discuss medication are all reasons to keep looking.
A Practical, Non-Alarmist Safety Note for Anyone Currently Using Tianeptine Products in Tennessee
If you have been using tianeptine and want to stop, you have options, and none of them require panicking. Because withdrawal can come on quickly, the safest path is to talk with a licensed provider about a planned, medically supported approach rather than stopping cold. The following public resources are free and confidential to contact:
SAMHSA National Helpline: 1-800-662-HELP (4357), available 24/7 in English and Spanish.
Find treatment near you: the SAMHSA treatment locator at findtreatment.gov.
Poison Help, for a bad reaction: call 1-800-222-1222 to reach your local poison center.
If you are in crisis: call or text 988 for the Suicide and Crisis Lifeline.
About this guide. This article is compiled from primary government and peer-reviewed sources, including the FDA, the Tennessee Department of Health, Tennessee state law, and published clinical case reports and reviews. Statistics are attributed and dated to their source and reflect the picture available in 2026. Because enforcement and product formulations change, verify current details before making legal or medical decisions.
This content is provided for information only. It is not medical advice, legal advice, or a diagnosis, and it does not claim medical review. Always consult a licensed clinician or attorney about your own circumstances.
References and Citations
- U.S. Food and Drug Administration. FDA warns consumers not to purchase or use any tianeptine product due to serious risks. Drug Safety and Availability. fda.gov
- Tennessee Department of Health. Tianeptine Trend Report 2024. tn.gov
- Tennessee Code Annotated § 39-17-408 (Controlled substances in Schedule II), listing tianeptine; enacted by Public Chapter 1135 (SB1997 / HB2043), effective July 1, 2022. law.justia.com
- Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a mu-opioid receptor agonist. Translational Psychiatry. 2014;4:e411.
- Tianeptine Misuse, Dependence, and Clinical Management: Three Case Reports and Literature Review. National Center for Biotechnology Information (PMC), 2026. ncbi.nlm.nih.gov
- Tianeptine misuse and addiction: A systematic review of withdrawal, toxicity, and clinical management. Drug and Alcohol Dependence, 2026. sciencedirect.com
- Concomitant Tianeptine and Alcohol Use Disorders: Diagnosis and Treatment with Buprenorphine-Naloxone. National Center for Biotechnology Information (PMC), 2025. ncbi.nlm.nih.gov
- America’s Poison Centers. National tianeptine exposure case data, 2023. poisoncenters.org
- Substance Abuse and Mental Health Services Administration (SAMHSA). FindTreatment.gov and National Helpline, 1-800-662-HELP (4357). findtreatment.gov